Access360
Strategic Intelligence on China’s Health Policy, Coverage, and Financing System
Access360 is NRDL+’s membership program for life sciences leaders seeking ongoing strategic intelligence on the health policy, coverage, and financing dynamics shaping medical technology access in China — helping members translate system change into clearer access strategy and better-informed commercial decisions.
What Access360 Enables
- Structured visibility into China’s evolving health policy, coverage, financing, and adoption landscape for medical technologies
- Deeper insights into how key developments may affect pricing assumptions, reimbursement strategy, utilization, and broader access and go-to-market planning
- Clearer assessment of China partnership exposure for companies commercializing through local partners, including how health policy, coverage, and financing shifts may affect partner strategy, product opportunity, and market assumptions
- Informed dialogue and alignment between global and China teams within life sciences companies
How Access360 Operates
Access360 translates policy developments, financing signals, and implementation dynamics into structured intelligence for decision-makers in life sciences companies.
Timely Interpretation and Implementation Deep Dives
Access360 delivers monthly member intelligence through timely interpretive notes as major developments unfold and implementation-focused deep dives that provide additional context to support members’ understanding and decision-making.
Member Q&A
Access360 members can have questions related to published briefings addressed through monthly written member responses. Responses are organized around main themes to clarify policy interpretation, implementation dynamics, and what these developments may mean for real-world decision-making.
China Access Outlook: Strategic Debrief
Access360 membership includes the Mid-Year and Annual China Access Outlook: Strategic Debriefs — on-demand executive briefings examining major developments shaping China’s health policy, pricing, coverage, financing, and adoption environment for medical technologies, with forward-looking implications for life sciences companies.
Access360 members also receive access to an exclusive live member discussion and Q&A following the Annual Strategic Debrief.
Membership Structure
Access360 is available through two membership options:
Individual Membership
For global and China-based decision-makers seeking structured visibility and strategic clarity across China’s evolving health policy, pricing, coverage, financing, and adoption landscape for medical technologies.
Annual Investment: USD 12,000, plus applicable taxes. Corporate invoicing available upon request.
Enterprise Membership
For organizations seeking a more efficient structure for multiple named Access360 users. Each named user receives individual Access360 member access, with no restriction by function or geography.
Memberships may be transferred during the annual term upon written request and approval if a named member changes roles or leaves the organization.